Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
29%(2 trials)

Phase Distribution

Ph not_applicable
7
78%
Ph phase_2
1
11%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
1(12.5%)
N/ANon-phased studies
7(87.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(7)
Other(1)

Detailed Status

Completed7
unknown1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (12.5%)
N/A7 (87.5%)

Trials by Status

completed778%
unknown111%
not_yet_recruiting111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
PROCEDURE
Total Trials
9